Pharmacia (Aug 2022)

Tobacco smokers as target group for complicated coronavirus infection

  • Petar Atanasov,
  • Maria Moneva-Sakelarieva,
  • Yozlem Kobakova,
  • Danka Obreshkova,
  • Ivaylo Ivanov,
  • Mariya Chaneva,
  • Mihaela Popova,
  • Valentina Petkova,
  • Stefka Ivanova

DOI
https://doi.org/10.3897/pharmacia.69.e91095
Journal volume & issue
Vol. 69, no. 3
pp. 791 – 800

Abstract

Read online Read online Read online

The aim of current study was to determine, retrospectively, possible correlations between smoking and the incidence, course severity, intubation rate, and mortality (by gender and age) in patients treated for complicated coronavirus infection in the internal medicine clinic at UMHATEM ”N. I. Pirogov” Sofia for the period 01.03.2020–31.12.2020. In a prospective study, the recovery period and immunogenesis in smokers and non-smokers within a one-year period after hospital discharge was investigated. The applied methods were: 1) computed tomography and blood gas analysis 2) chemiluminescent immunoassay for the qualitative determination of total IgM, IgA and IgG anti-SARS-CoV2 AB. Results showed that the part of non-smokers with a positive PCR test is significantly higher compared to the group of former and current smokers. The data obtained from the study confirmed that Covid infection is much more severe among smokers and former smokers with a higher levels of inflammatory markers noticed among the smoking group.